Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced exhibit booth activities showcasing its compact, in-office MRI system and its MRI compatible Robot under development at two upcoming trade conferences.
American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting
Promaxo is hosting an exhibit showcasing its minimally-invasive, FDA cleared and patient-centric MRI System and its MRI compatible Robot under development at the upcoming American Society for Radiation Oncology (ASTRO) Annual Meeting in San Diego, California on October 1 - 4, 2023.
The Company will be at booth #1105, and exhibits will be held in person on October 1-3, 2023, from 10:00 AM – 5:00 PM PDT each day.
Western Section American Urological Association (AUA) 99th Annual Meeting
Promaxo is hosting an exhibit showcasing its minimally-invasive, FDA cleared and patient-centric MRI System and its MRI compatible Robot under development at the upcoming Western Section AUA Annual Meeting in Lake Tahoe, California on October 1 - 5, 2023.
The Company will be at booth #TT02, and exhibits will be held in person on October 2-4, 2023.
Additionally, the Company will be hosting a private event at the Everline Resort & Spa for those interested in learning more about the Promaxo MRI on September 30th.
Individuals interested in attending the private event can contact [email protected] for more information.
“We are looking forward to returning to ASTRO and WSAUA this year following the strong progress we made during the first half of the year,” said Dr. Amit Vohra, Founder and CEO of Promaxo. “We continue to see that our innovative technologies and capabilities are resonating with physicians, and we are excited to reconnect with the community of radiation oncology and urology professionals. At Promaxo, we remain committed to advancing cancer treatment programs leveraging our portable MRI-system equipped for in-office diagnostic biopsies and treatments.”